SpIntellx is disrupting the precision medicine pathology market by creating unprecedented predictive knowledge from patient disease tissue samples creating a new paradigm for the most valuable use cases in personalized therapeutic strategies, clinical trial stratification, advanced prognostics and companion diagnostics, and identification of novel targets for drug discovery.